Yüklüyor......
A tandem CD19/CD20 CAR lentiviral vector drives on-target and off-target antigen modulation in leukemia cell lines
BACKGROUND: Clinical success with chimeric antigen receptor (CAR)- based immunotherapy for leukemia has been accompanied by the associated finding that antigen-escape variants of the disease are responsible for relapse. To target hematologic malignancies with a chimeric antigen receptor (CAR) that t...
Kaydedildi:
Yayımlandı: | J Immunother Cancer |
---|---|
Asıl Yazarlar: | , , , , , , , , |
Materyal Türü: | Artigo |
Dil: | Inglês |
Baskı/Yayın Bilgisi: |
BioMed Central
2017
|
Konular: | |
Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5433150/ https://ncbi.nlm.nih.gov/pubmed/28515942 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-017-0246-1 |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|